LOADING
Comparing Mastercard Inc (MA) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | JNJ |
|---|---|---|
| Price | $580.63 | $270.24 |
| Change Today | +1.18% | +1.07% |
| Market Cap | $508.6B | $651.3B |
| P/E Ratio | 31.5 | 31.4 |
| Forward P/E | 29.1 | 23.2 |
| PEG Ratio | 1.76 | 4.73 |
| EPS | $18.41 | $8.62 |
| Revenue Growth (YoY) | 14.1% | 6.6% |
| Profit Margin | 46.3% | 21.5% |
| Return on Equity | 241.2% | 25.7% |
| Dividend Yield | 0.59% | 1.96% |
| Beta | 0.73 | 0.23 |
| 52-Week High | $597.89 | $276.47 |
| 52-Week Low | $463.74 | $170.33 |
| Volume | 2.2M | 6.2M |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.